Scientific Sessions 2024  /  Pearls to Improve Peri-Procedural Care  /  Periprocedural anemia: do we need to do anything about it?
Logo

American Heart Association

  120
  0

Final ID:

Periprocedural anemia: do we need to do anything about it?

If you are unable to find a person you would like to add, enter their first name, last name, email, institution, role title, and Primary or Alternate below. Only add them once you have ensured you cannot find them in the AHA Database::
  • Raphael, Jacob  ( Thomas Jefferson University , Philadelphia , Pennsylvania , United States )
  • Shore-lesserson, Linda  ( NORTHWELL MEDICAL CENTER , Manhasset , New York , United States )
  • Guinn, Nicole  ( Duke , Durham , North Carolina , United States )
  • Hensley, Nadia  ( JOHNS HOPKINS UNIVERSITY , Baltimore , Maryland , United States )
  • Mazer, David  ( St Michaels Hospital, Toronto , Toronto , Ontario , Canada )
  • Muehlschlegel, Jochen  ( JOHNS HOPKINS UNIVERSITY , Baltimore , Maryland , United States )
    • Author Disclosures:
    Jacob Raphael: DO have relevant financial relationships ; Speaker:CSL Behring:Past (completed) ; Advisor:Octapharma:Past (completed) ; Speaker:Octapharma:Past (completed) ; Advisor:Werfen:Past (completed) ; Research Funding (PI or named investigator):CSL:Expected (by end of conference) | Linda Shore-Lesserson: DO NOT have relevant financial relationships | Nicole Guinn: No Answer | Nadia Hensley: No Answer | David Mazer: DO have relevant financial relationships ; Consultant:Amgen:Active (exists now) ; Consultant:Trimedic:Active (exists now) ; Other (please indicate in the box next to the company name):Takeda:Past (completed) ; Consultant:Sandoz:Active (exists now) ; Consultant:PhaseBio:Past (completed) ; Consultant:Werfen:Active (exists now) ; Other (please indicate in the box next to the company name):Delex:Past (completed) ; Consultant:Cytosorbents:Active (exists now) ; Other (please indicate in the box next to the company name):Cerus:Past (completed) ; Consultant:Cardior:Past (completed) ; Consultant:BoehringerIngelheim:Active (exists now) ; Consultant:Biotest:Active (exists now) ; Consultant:BioAge:Past (completed) ; Consultant:Alexion:Active (exists now) ; Consultant:AstraZeneca:Past (completed) | JOCHEN MUEHLSCHLEGEL: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Pearls to Improve Peri-Procedural Care

Monday, 11/18/2024 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Periprocedural Atrial Fibrillation: What To Do?

Muehlschlegel Jochen, Kleiman Amanda, Howard-quijano Kimberly, Boskovski Marko, Kaneko Tsuyoshi

Panel

Rong Lisa

More abstracts from these authors:
How can we mitigate kidney dysfunction after procedures?

Meersch Melanie, Fox Amanda, Mazer David, Shaw Andrew, Khanna Ashish, Muehlschlegel Jochen

Periprocedural management of anticoagulation

Methvin Laura, Vandenbriele Christophe, Ciancarelli James, Horowitz James, Bennett Courtney, Shore-lesserson Linda, Muehlschlegel Jochen, Tanaka Kenichi, Douketis James

You have to be authorized to contact abstract author. Please, Login
Not Available